Ambey Laboratories IPO vs Visaman Global Sales IPO

Comparision between Ambey Laboratories IPO and Visaman Global Sales IPO.

IPO Details

Ambey Laboratories IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Visaman Global Sales IPO is a SME Fixed Price Issue proposed to list at NSE SME.

	Ambey Laboratories IPO	Visaman Global Sales IPO
Logo
Issue Category	SME	SME
Issue Type	IPO	IPO
Process Type	Book Built Issue	Fixed Price Issue
Listing At	NSE SME	NSE SME
Lead Managers	Fast Track Finsec Pvt Ltd	Shreni Shares Limited
Registrar	Link Intime India Private Ltd	Link Intime India Private Ltd
Market Maker	Nikunj Stock Brokers Limited	Shreni Shares Limited
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor
IPO Allotment URL		IPO Allotment URL

Issue Size and Price

The total issue size of Ambey Laboratories IPO is up to ₹44.68 Cr whereas the issue size of the Visaman Global Sales IPO is up to ₹16.05 Cr. The final issue price of Ambey Laboratories IPO is and of Visaman Global Sales IPO is ₹43.00 per share.

	Ambey Laboratories IPO	Visaman Global Sales IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)	₹65.00 per share
Issue Price (Upper)	₹68.00 per share
Issue Price (Final)		₹43.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size	2000 shares	3000 shares
Fresh Issue Size	62,58,000 shares	37,32,000 shares
Fresh Issue Size (Amount)	up to ₹42.55 Cr	up to ₹16.05 Cr
OFS Issue Size	3,12,000 shares
OFS Issue Size (Amount)	up to ₹2.12 Cr
Issue Size Total	65,70,000 shares	37,32,000 shares
Issue Size Total (Amount)	up to ₹44.68 Cr	up to ₹16.05 Cr

IPO Timetable

Ambey Laboratories IPO opens on Jul 04, 2024, while Visaman Global Sales IPO opens on Jun 24, 2024. The closing date of Ambey Laboratories IPO and Visaman Global Sales IPO is Jul 08, 2024, and Jun 26, 2024, respectively.

	Ambey Laboratories IPO	Visaman Global Sales IPO
Anchor Bid Date	Jul 03, 2024
Issue Open	Jul 04, 2024	Jun 24, 2024
Issue Close	Jul 08, 2024	Jun 26, 2024
Basis Of Allotment (Tentative)	Jul 09, 2024	Jun 27, 2024
Initiation of Refunds (Tentative)	Jul 10, 2024	Jun 28, 2024
Credit of Share (Tentative)	Jul 10, 2024	Jun 28, 2024
Listing date (Tentative)	Jul 11, 2024	Jul 01, 2024
Anchor Lockin End date 1	Aug 08, 2024
Anchor Lockin End date 2	Oct 07, 2024

Financials

Ambey Laboratories IPO P/E ratio is 27.81, as compared to Visaman Global Sales IPO P/E ratio of 38.25.

Ambey Laboratories IPO

Visaman Global Sales IPO

Financial

Ambey Laboratories Limited Financial Information (Restated)

Period Ended	31 Jan 2024	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	8,620.84	5,761.85	5,592.94	4,461.80
Revenue	10,043.69	10,743.47	8,511.19	8,241.54
Profit After Tax	607.73	456.93	357.47	1,033.67
Net Worth	3,431.34	2,363.60	1,906.67	-786.39
Reserves and Surplus	1,562.46	588.66	131.73	-1,275.74
Total Borrowing	2,005.44	1,365.22	1,804.86	3,292.98
Amount in ₹ Lakhs

Visaman Global Sales Limited Financial Information (Restated)

Visaman Global Sales Limited's revenue increased by 16.04% and profit after tax (PAT) rose by 19.72% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended	31 Dec 2023	31 Mar 2023	31 Mar 2022	31 Mar 2021
Assets	8,001.69	5,863.95	3,982.42	2,727.20
Revenue	20,691.39	37,605.01	32,407.29	13,636.19
Profit After Tax	101.61	113.33	94.66	33.47
Net Worth	1,095.31	993.70	660.38	565.72
Reserves and Surplus	395.31	293.70	180.38	85.72
Total Borrowing	5,690.85	4,345.69	1,386.10	710.34
Amount in ₹ Lakhs

Promoter Shareholding (Pre-Issue)

94.97%

100.00%

Promoter Shareholding (Post-Issue)

72.98%

P/E Ratio

27.81

38.25

Market Cap

₹171.64 Cr.

₹59.39 Cr.

ROE

20.80%%

9.28%%

ROCE

13.14%%

8.02%%

Debt/Equity

0.58

5.2

EPS

₹2.44

₹1.12

RoNW

20.80%%

9.28%%

Shares Offered

In the Ambey Laboratories IPO retail investors (RII) are offered while in Visaman Global Sales IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Ambey Laboratories IPO and 0 shares in Visaman Global Sales IPO.

	Ambey Laboratories IPO	Visaman Global Sales IPO
Anchor Investor Reserveration
Market Maker Reserveration	3,12,000 shares	1,92,000 shares
QIB		0 shares
NII		17,70,000 shares
RII		17,70,000 shares
Employee		0 shares
Others
Total		35,40,000 shares

Bids Received (Subscription)

Ambey Laboratories IPO subscribed in total, whereas Visaman Global Sales IPO subscribed 42.20x.

	Ambey Laboratories IPO	Visaman Global Sales IPO
QIB (times)
NII (times)		28.12x
Big NII (times)
Small NII (times)
RII (times)		51.54x
Employee (times)
Other (times)
Total (times)		42.20x

Compare with others

Ambey Laboratories IPO	Visaman Global Sales IPO
Nephro Care India IPO	Ambey Laboratories IPO
Diensten Tech IPO	Nephro Care India IPO
Visaman Global Sales IPO	Diensten Tech IPO
Mason Infratech IPO	Mason Infratech IPO
Petro Carbon and Chemicals IPO	Petro Carbon and Chemicals IPO
	Sylvan Plyboard IPO
	Shivalic Power Control IPO
	Divine Power IPO

Comments

Add a public comment...